Lymphocytic Leukemia, Acute Clinical Trials

Duarte : City of Hope

A Phase 1, Open-Label, Dose-Escalation Study of SGN-CD19A in Patients with B-Lineage Acute Lymphoblastic Leukemia and Highly Aggressive Lymphomas

Duarte : City of Hope

A Phase 2, Controlled Trial, of a Single Prohema-CB Unit (ex vivo CXCR4-Upregulated CD34+ Hematopoietic Progenitor Cells, Cord Blood) as Part of a Double Umbilical Cord Blood Transplant Following Myeloablative Conditioning for Patients Age 15-55 years with Hematologic Malignancies

Duarte : City of Hope

BMT CTN 0903 (AMC-080): Allogeneic Hematopoietic Cell Transplantation for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals

Duarte : City of Hope

Childhood Cancer Survivor Study

Duarte : City of Hope

COG AALL0433: Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies

Duarte : City of Hope

COG AALL06N1: A Study of Neurocognitive Function in Children Treated for ALL - A Group-Wide, Non-Therapeutic Companion Study to AALL0232

Duarte : City of Hope

COG AALL07P1: A Phase II Pilot Trial of Bortezomib (PS-341, Velcade, IND#58,443) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymhoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)

Duarte : City of Hope

COG ACCL0934: A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)

Duarte : City of Hope

Phase I-II Study of Escalating Doses of Large Field Image-Guided Intensity Modulated Radiation Therapy (IMRT) using Helical Tomotherapy in Combination with Etoposide VP16) and Cytoxan as a Preparative Regimen for Allogeneic Hematopoietic Stem Cell (HSC) Transplantation for Patients with Poor Risk Acute Lymphocytic Leukemia (ALL) or Poor Risk Acute Myelogenous Leukemia (AML)

Tacoma : MultiCare Health System

A Study of 131I-Tositumomab (Bexxar®) Consolidation in Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission